20 Jul Genetix Biotherapeutics
Posted at 20:12h
in
Brian Riley, President and Chief Technology Officer
Oct. 6 | 11:45am | FLW Ballroom G
Somerville, MA
(Private)
Genetix Biotherapeutics Inc. is a privately held, commercial-stage biotechnology company dedicated to delivering one-time transformative treatments for patients with severe rare diseases. Backed by more than 30 years of pioneering genetic medicine innovation, the company has FDA-approved treatments for sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy that directly treat the underlying cause of disease. Genetix is committed to commercial execution, scaling patient access, and improving the treatment experience for patients and providers.